Insider Transactions Reported by 25 Insiders of Longeveron Inc.

Symbol
LGVN on Nasdaq
Location
Miami, FL

Insiders trading volume in the past year

Longeveron Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Joshua Hare Chief Scientific Officer, Director, 10%+ Owner $1.01M -$7.37K -0.72% 15 Jul 2025
Mohamed Wa'el Ahmed Hashad Chief Executive Officer $556K 15 Jul 2025
Rock Soffer Director $298K -$29.4K -8.97% 15 Jul 2025
Paul T. Lehr General Counsel, Secretary $261K 01 Oct 2025
Kwan-Hong Christopher Min Chief Medical Officer $199K 04 Apr 2022
Lisa Locklear Chief Financial Officer $177K 01 Oct 2025
Geoff Green Ceo $175K 04 Apr 2022
Nataliya Agafonova Chief Medical Officer $168K 01 Oct 2025
Devin Blass CTO & SVP of CMC $157K 01 Oct 2025
James Nathaniel Powell Chief Executive Officer $95.1K 01 Oct 2025
Khoso Baluch Director $74.6K 11 Aug 2025
James Clavijo CFO and Treasurer $61.9K 27 Jun 2023
Ursula Ungaro Director $54.1K 15 Jul 2025
Neil E. Hare Director $50.8K 15 Aug 2024
Richard N. Kender Director $43.6K 15 Jul 2025
Roger Joseph Hajjar Director $43.6K 15 Jul 2025
Neha J. Motwani Director $43.6K 15 Jul 2025
George A. Paletta Jr. Director $25.6K 01 Oct 2025
JEFFREY PFEFFER Director $19.6K 28 Dec 2023
Cathy Ross Director $13.1K 10 Jan 2024
DOUGLAS W. LOSORDO Director 21 Dec 2023
Todd Girolamo Director 21 Dec 2022
Erin Borger Director 21 Dec 2022
DS MED LLC 10%+ Owner 17 May 2022
Donald M. Soffer Director 21 Dec 2022

Recent Insider Transactions by Companies or Individuals for Longeveron Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.